高级搜索

乳腺癌耐药蛋白ABCG2对胰腺癌SW1990细胞耐药性影响的实验

王飞通, 周兵, 刘小云, 汪正伟, 牛坚, 魏鑫, 刘斌

王飞通, 周兵, 刘小云, 汪正伟, 牛坚, 魏鑫, 刘斌. 乳腺癌耐药蛋白ABCG2对胰腺癌SW1990细胞耐药性影响的实验[J]. 肿瘤防治研究, 2014, 41(10): 1070-1073. DOI: 10.3971/j.issn.1000-8578.2014.10.003
引用本文: 王飞通, 周兵, 刘小云, 汪正伟, 牛坚, 魏鑫, 刘斌. 乳腺癌耐药蛋白ABCG2对胰腺癌SW1990细胞耐药性影响的实验[J]. 肿瘤防治研究, 2014, 41(10): 1070-1073. DOI: 10.3971/j.issn.1000-8578.2014.10.003
WANG Feitong, ZHOU Bing, LIU Xiaoyun, WANG Zhengwei, NIU Jian, WEI Xin, LIU Bin. Effect of ABCG2 Expression on Chemoresistance of Pancreatic Carcinoma Cell Line SW1990[J]. Cancer Research on Prevention and Treatment, 2014, 41(10): 1070-1073. DOI: 10.3971/j.issn.1000-8578.2014.10.003
Citation: WANG Feitong, ZHOU Bing, LIU Xiaoyun, WANG Zhengwei, NIU Jian, WEI Xin, LIU Bin. Effect of ABCG2 Expression on Chemoresistance of Pancreatic Carcinoma Cell Line SW1990[J]. Cancer Research on Prevention and Treatment, 2014, 41(10): 1070-1073. DOI: 10.3971/j.issn.1000-8578.2014.10.003

乳腺癌耐药蛋白ABCG2对胰腺癌SW1990细胞耐药性影响的实验

详细信息
    作者简介:

    王飞通(1983-),男,博士,主治医师,主要从事胰腺肿瘤的临床及基础研究

    通信作者:

    刘斌,E-mail:liubin.xy@163.com

  • 中图分类号: R735.9

Effect of ABCG2 Expression on Chemoresistance of Pancreatic Carcinoma Cell Line SW1990

  • 摘要: 目的 探讨吉西他滨诱导胰腺癌细胞SW1990中ABCG2的表达及其与化疗耐药的关系。方法 胰腺癌细胞SW1990用DMEM培养液常规培养,用0.82 mg/ml吉西他滨作用SW1990细胞24、48和72 h后,使用流式细胞仪测其细胞凋亡率,Western blot检测ABCG2蛋白的表达,RT-PCR检测ABCG2 mRNA的表达,并且分析ABCG2表达水平与化疗耐药的关系。结果 0.82 mg/ml吉西他滨作用SW1990细胞24、48和72 h后,细胞凋亡率分别为(21.1±0.61)%、(13.4±2.17)%、(6.4±1.34)%,不同时间点两两相比P均<0.05。0.82 mg/ml吉西他滨作用SW1990细胞24、48、72 h后与对照组相比,ABCG2 mRNA分别上升了(2.21±0.11)倍、(3.30±0.08)倍和(4.72±0.12)倍,蛋白上升了(2.17±0.14)倍、(3.61±0.09)倍和(4.98±0.13)倍,且组间比较P均<0.05,有统计学意义。结论 吉西他滨能抑制胰腺癌细胞SW1990的增殖,但随着时间延长,药物抵抗逐渐增强,这可能与吉西他滨作用细胞后上调ABCG2的表达有关。
    Abstract: Objective To explore the relationship between chemoresistance to gemcitabine and ABCG2 expression in pancreatic carcinoma cell line SW1990. Methods The pancreatic carcinoma cell line SW1990 was cultured by DMEM and treated with 0.82 mg/ml gemcitabine for 24, 48 and 72 h. Then apoptosis rate was measured by flow cytometry, ABCG2 expression was examined by Western blot and ABCG2 mRNA expression was detected by RT-PCR. The relationship between ABCG2 expression and chemoresistance to gemeitabine was analyzed. Results After treated with 0.82 mg/ml gemeitabine for 24, 48 and 72 h, the apoptosis rates were(21.1±0.61)%, (13.4±2.17)%, (6.4±1.34)%, respectively (comparison between different time points, P<0.05); moreover, compared with control group, ABCG2 mRNA expression were increased by(2.21±0.11), (3.30±0.08) and (4.72±0.12) times and the protein expression were increased by(2.17±0.14), (3.61±0.09) and (4.98±0.13) times respectively (comparison between groups, P<0.05). Conclusion Gemcitabine could inhibit cell proliferation of pancreatic carcinoma cell line SW1990, but the chemoresistance would be enhanced gradually with time, which may be related with increased ABCG2 expression.
  • [1] Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[J]. CA Cancer J Clin, 2012, 62(1):10-29.
    [2] Chua YJ, Zalcberg JR. Pancreatic cancer--is the wall crumbling?[J]. Ann Oncol, 2008, 19(7): 1224-30.
    [3] Neoptolemos JR, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer[J]. N Engl J Med, 2004, 350(12):1200-10.
    [4] Burris HA 3rd, Moore MJ, Andersen J, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patient with advanced pancreas cancer: a randomized trial[J]. J Clin Oncol, 1997, 15(6): 2403-13.
    [5] Rothenberg ML. New developments in chemotherapy for patients with advanced pancreas cancer[J]. Oncology (Williston Park), 1996, 10 (9 Suppl): 18-22.
    [6] Natarajan K, Xie Y, Baer MR, et al. Role of breast cancer resistance protein(BCRP/ABCG2) in cancer drug resistance[J]. Biochem Pharmacol,2012,83(8): 1084-103.
    [7] Mosaffa F, Kalalinia F, Parhiz BH, et al. Tumor necrosis factor alpha induces stronger cytotoxicity in ABCG2-overexpressing resistant breast cancer cells compared with their drug-sensitive parental line[J]. DNA Cell Biol, 2011, 30(6): 413-8.
    [8] Peng H, Qi J, Dong Z, et al. Dynamic vs static ABCG2 inhibitors to sensitize drug resistant cancer cells[J]. PLoS One, 2010, 5(12): e15276.
    [9] Cusatis G, Sparreboom A. Pharmacogenomic importance of ABCG2[J]. Pharmacogenomics, 2008, 9(8): 1005-9.
    [10] Wielinga P,Hooijberg JH,Gunnarsdottir S,et al. The human multidrug resistance protein MRP5 transports folates and can mediate cellular resistance against antifolates[J]. Cancer Bes, 2005, 65 (10): 4425-30.
    [11] Wang YH, Li F, Luo B, et al. A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics[J]. Neoplasma, 2009, 56(5): 371-8.
    [12] Yajima T, Ochiai H, Uchiyama T, et al. Resistance to cytotoxic chemotherapy-induced apoptosis in side population cells of human oral squamous cell line Ho-1-N-1[J]. Int J Oncol, 2009, 35(2): 273-80.
    [13] Dou J, Wen P, Hu W, et al. Identifying tumor stem-like cells in mouse melanoma cell lines by analyzing the characteristics of side population of cells[J]. Cell Biol Int, 2009, 33(8): 807-15.
    [14] Benderra Z,Faussat AM, Sayada L, et al.Breast cancer resistance protein an P-glycoprotein in 149 adult acute myeloid leukemias[J]. Clin Cancer Res, 2004,10(23):7896-902.
    [15] Zen Y,Fujii T,Yoshikawa S,et al.Histological and culture studies with respect to ABCG2 expression support the existence of a cancer cell hierarchy in human hepatocellular carcinoma[J]. Am J Pathol, 2007, 170(5): 1750-62.
    [16] Summer R, Kotton DN,SunX,et al. Side population cells and Bcrpl expression in lung[J].Am J Physiol Lung Cell Mol Physiol, 20 03, 285(1):L97-104.
计量
  • 文章访问数:  2715
  • HTML全文浏览量:  529
  • PDF下载量:  490
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-01-09
  • 修回日期:  2014-02-11
  • 刊出日期:  2014-10-24

目录

    Corresponding author: LIU Bin, liubin.xy@163.com

    1. On this Site
    2. On Google Scholar
    3. On PubMed

    /

    返回文章
    返回
    x 关闭 永久关闭